Cargando…

Non-coding RNAs underlie genetic predisposition to breast cancer

BACKGROUND: Genetic variants identified through genome-wide association studies (GWAS) are predominantly non-coding and typically attributed to altered regulatory elements such as enhancers and promoters. However, the contribution of non-coding RNAs to complex traits is not clear. RESULTS: Using tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moradi Marjaneh, Mahdi, Beesley, Jonathan, O’Mara, Tracy A., Mukhopadhyay, Pamela, Koufariotis, Lambros T., Kazakoff, Stephen, Hussein, Nehal, Fachal, Laura, Bartonicek, Nenad, Hillman, Kristine M., Kaufmann, Susanne, Sivakumaran, Haran, Smart, Chanel E., McCart Reed, Amy E., Ferguson, Kaltin, Saunus, Jodi M., Lakhani, Sunil R., Barnes, Daniel R., Antoniou, Antonis C., Dinger, Marcel E., Waddell, Nicola, Easton, Douglas F., Dunning, Alison M., Chenevix-Trench, Georgia, Edwards, Stacey L., French, Juliet D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947989/ https://www.ncbi.nlm.nih.gov/pubmed/31910864 http://dx.doi.org/10.1186/s13059-019-1876-z

Ejemplares similares

Chromatin interactome mapping at 139 independent breast cancer risk signals
por: Beesley, Jonathan, et al.
Publicado: (2020)

High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
por: Johnston, Rebecca L., et al.
Publicado: (2016)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
por: Momeny, Majid, et al.
Publicado: (2015)

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
por: Bessette, Darrell C., et al.
Publicado: (2015)

A Molecular and Morphological Deep-Dive Into Metaplastic Breast Cancers
por: McCart Reed, Amy E, et al.
Publicado: (2019)

LobSig is a multigene predictor of outcome in invasive lobular carcinoma
por: McCart Reed, Amy E., et al.
Publicado: (2019)

Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
por: Croft, Priyakshi Kalita-de, et al.
Publicado: (2021)

NDRG1 in Cancer: A Suppressor, Promoter, or Both?
por: Joshi, Vaibhavi, et al.
Publicado: (2022)

Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950
por: McCart Reed, Amy E., et al.
Publicado: (2021)

The Genomic Landscape of Lobular Breast Cancer
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Tumor Signature Analysis Implicates Hereditary Cancer Genes in Endometrial Cancer Development
por: Kondrashova, Olga, et al.
Publicado: (2021)

An Update on the Molecular Pathology of Metaplastic Breast Cancer
por: McCart Reed, Amy E, et al.
Publicado: (2021)

Invasive lobular carcinoma of the breast: the increasing importance of this special subtype
por: McCart Reed, Amy E., et al.
Publicado: (2021)

Using whole-genome sequencing data to derive the homologous recombination deficiency scores
por: de Luca, Xavier M., et al.
Publicado: (2020)

Candidate Causal Variants at the 8p12 Breast Cancer Risk Locus Regulate DUSP4
por: Glubb, Dylan M., et al.
Publicado: (2020)

Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics
por: Reed, Amy E McCart, et al.
Publicado: (2015)

Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

Toothache of Horses
por: McCart, T. S.
Publicado: (1887)

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study
por: Kutasovic, Jamie R, et al.
Publicado: (2018)

Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers
por: Nones, K, et al.
Publicado: (2019)

Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer
por: Kutasovic, Jamie R., et al.
Publicado: (2020)

The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes
por: Johnson, Julie K, et al.
Publicado: (2012)

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

The importance of using public data to validate reported associations
por: Chenevix-Trench, Georgia, et al.
Publicado: (2018)

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer
por: Saunus, Jodi M., et al.
Publicado: (2022)

Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer
por: Kane, Alexandra M., et al.
Publicado: (2020)

Long noncoding RNAs in cancer: mechanisms of action and technological advancements
por: Bartonicek, Nenad, et al.
Publicado: (2016)

Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms
por: Feng, Yufan, et al.
Publicado: (2023)

Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1
por: Kalaw, Emarene, et al.
Publicado: (2020)

Phenotypic drift in metastatic progression of breast cancer: A case report with histologically heterogeneous lesions that are clonally related
por: Kutasovic, Jamie R., et al.
Publicado: (2020)

SNPs in lncRNA Regions and Breast Cancer Risk
por: Suvanto, Maija, et al.
Publicado: (2020)

Editorial: Molecular mechanisms in breast cancer progression and metastasis
por: Fedele, Monica, et al.
Publicado: (2022)

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status
por: Flanagan, JM, et al.
Publicado: (2010)

Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
por: Raghavendra, Ashwini, et al.
Publicado: (2018)

Redefining normal breast cell populations using long noncoding RNAs
por: Bitar, Mainá, et al.
Publicado: (2023)

CRISPR screens identify gene targets at breast cancer risk loci
por: Tuano, Natasha K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qdipiu10b6b9gsnrhjhu0cjqpi